Sotac Pharmaceuticals Ltd Share Price
(SOTAC)
₹1250%
as on 01:32PM, 23 Apr 2025
Sotac Pharmaceuticals Ltd Performance
- ₹125Day's Price Range₹125
52 Week's Low
52 Week's High
₹87.152-Week Price Range₹202.8
| Returns % | |
| 1 Month Return | -7.58 % |
| 3 Month Return | + 13.64 % |
| 1 Year Return | -0.79 % |
| Market Stats | |
| Previous Close | ₹125.00 |
| Open | ₹125.00 |
| Volume | 1,200.00 |
| Upper Circuit | ₹131.25 |
| Lower Circuit | ₹118.75 |
| Market Cap | ₹138.13Cr |
Sotac Pharmaceuticals Ltd Fundamentals
P/E Ratio
0PEG Ratio
0Market Cap
₹23.89 Cr
P/B Ratio
1.98
EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
7.86
Key events for Sotac Pharmaceuticals Ltd
Sotac Pharmaceuticals' High P/E Ratio Raises Concerns - 28 Jun, 2024
Sotac Pharmaceuticals has a high P/E ratio of 39.7x, which may be unjustified despite strong recent earnings growth of 37%. Shareholders may face disappointment if the P/E falls to levels more in line with recent growth rates.Sotac Pharmaceuticals Receives Order Worth Rs. 17.13 Crores - 26 Jun, 2024
Shares of Sotac Pharmaceuticals surged by 20% after receiving an order worth Rs. 17.13 crores from Rajasthan Medical Services Corporation Limited. The company's revenue increased by 35% and net profits magnified by 100% in FY23-24. Key customers include Cadila Pharma, Intas Pharma, and Eris Lifesciences. Promoters hold a stake of 72.85%, while FIIs hold 8.99% of the shares.Sotac Pharmaceuticals' Financial Prospects Look Decent Despite Recent Stock Weakness - 05 Jun, 2024
Despite Sotac Pharmaceuticals' stock being down 33% over the past three months, its key financial indicators look decent. The company's ROE suggests that the stock could potentially rise in the long-term given more resilient long-term fundamentals.
Insights on Sotac Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, SOTAC stock has moved up by 13.6%
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 18.16% to 18.27% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 25.5 Cr → 27.8 Cr (in ₹), with an average increase of 8.3% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 72.85% of holdings in Sep 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 8.99% to 8.88% in Sep 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 1.64 Cr → 0.46 Cr (in ₹), with an average decrease of 39.9% per quarter
Sotac Pharmaceuticals Ltd Financials
Sotac Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 72.85% | 0.00 | |
| Foreign Institutions | 8.88% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 18.27% | 0.60 | |
| Others | 0% | 0.00 |
Sotac Pharmaceuticals Ltd Key Indicators
Sotac Pharmaceuticals Ltd Valuation
Sotac Pharmaceuticals Ltd in the last 5 years
Lowest (13.14x)
April 24, 2023
Today (30.86x)
April 22, 2025
Industry (53.69x)
April 22, 2025
Highest (44.90x)
July 16, 2024
Sotac Pharmaceuticals Ltd Earnings and Dividends
Sotac Pharmaceuticals Ltd Earnings Results
Sotac Pharmaceuticals Ltd’s net profit fell -29.23% since last year same period to ₹0.46Cr in the Q2 2024-2025. On a quarterly growth basis, Sotac Pharmaceuticals Ltd has generated -68.28% fall in its net profits since last 3-months.
Read More about Earnings Results
Sotac Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Sotac Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Sotac Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹23.89 Cr | 106.42% | 0.50 | NA | NA | |
| NA | ₹1,468.50 Cr | -5.28% | 0.62 | ₹57 Cr | ₹398 Cr | |
| NA | ₹5,658.04 Cr | 452.63% | 0.50 | ₹33 Cr | ₹204 Cr | |
| NA | ₹19.71 Cr | 404.56% | 0.50 | NA | NA | |
| NA | ₹3,211.38 Cr | 65.81% | 0.65 | -₹2 Cr | ₹559 Cr |
About Sotac Pharmaceuticals Ltd
Revenue: ₹27.35Cr as on September 2024 (Q3 24)
Net Profit: ₹0.42Cr as on September 2024 (Q3 24)
Listing date: 13 Apr, 2023
Chairperson Name: Sharadkumar Dashrathbhai Patel
| Organisation | Sotac Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Sotac Pharmaceuticals Ltd
What is Sotac Pharmaceuticals Ltd price today?
Sotac Pharmaceuticals Ltd share price today stands at ₹125, Open: ₹125, Previous Close: ₹125, High: ₹125, Low: ₹125, 52 Week High: ₹202.8, 52 Week Low: ₹87.1.
How to Buy Sotac Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Sotac Pharmaceuticals Ltd shares
What are today's traded volumes of Sotac Pharmaceuticals Ltd?
Today's traded volume of Sotac Pharmaceuticals Ltd(SOTAC) is 1,200.00.
What is today's market capitalisation of Sotac Pharmaceuticals Ltd?
Today's market capitalisation of Sotac Pharmaceuticals Ltd(SOTAC) is ₹138.13Cr.
What is the 52 Week High and Low Range of Sotac Pharmaceuticals Ltd?
How much percentage Sotac Pharmaceuticals Ltd is down from its 52 Week High?
Sotac Pharmaceuticals Ltd (SOTAC) share price is ₹125. It is down -38.36% from its 52 Week High price of ₹202.8
How much percentage Sotac Pharmaceuticals Ltd is up from its 52 Week low?
Sotac Pharmaceuticals Ltd (SOTAC) share price is ₹125. It is up 43.51% from its 52 Week Low price of ₹87.1